Radiotherapy: a valuable tool in a time of crisis
31 March, 2020
Our SABR UK clinical director of stereotactic radiotherapy, Dr James Good, shares his insights into SABR These are unprecedented times in healthcare. The rapid global spread of a virus that affects both older people and younger people, poorly people and well people, will continue to have a profound impact on our economy and the way…
26 March, 2020
Advanced radiotherapy in the treatment of breast cancer – reasons to be positive
Published in Jewish Chronicle Breast cancer is the most common cancer in women. According to Cancer Research UK, one in eight will be diagnosed with it at some point in their lifetime, although it is more likely to affect women beyond the age of 50. However, today more than ever, there is reason for optimism…
5 March, 2020
GenesisCare, the NHS and Public Health England (PHE) are extremely well prepared for outbreaks of new infectious diseases. The NHS has put in place measures to ensure the safety of all patients and NHS staff while also ensuring services are available to the public as normal. The risk to the general public is moderate. If…
13 February, 2020
For the first time, patients in the UK will have access to Brainlab Mixed Reality Viewer as part of their cancer treatment; a new way for physicians to provide visualisation of treatment to their patients, actively involving them in their own cancer care. GenesisCare has launched the revolutionary new technology at its Oxford centre for…
13 December, 2019
FLORIDA, U.S. – Cancer patients in communities across the U.S. are expected to benefit from increased access to high quality cancer care, with U.S. provider of radiation therapy and integrated cancer treatments, 21st Century Oncology, to become part of Australian cancer and cardiac care company, GenesisCare. The combined experience and reach of 21st Century Oncology’s…
10 December, 2019
For the first time, patients in the UK now have access to MRIdian – the world’s smartest radiotherapy treatment – at GenesisCare’s treatment centre in Oxford. This technology combines magnetic resonance imaging (MRI) techniques with extremely precise radiotherapy beams, enabling the clinician to visualise the exact position and shape of a patient’s tumour in real…
14 November, 2019
Our GenesisCare centre in Windsor is rated ‘Outstanding’ by the Care Quality Commission (CQC)
We are delighted to announce that our centre in Windsor has been rated Outstanding in a recent Care Quality Commission (CQC) inspection. The inspectors’ assessment of the centre on 24 to 25 June 2019 covered the five core CQC domains- Safe, effective, caring, responsive and well-led. The CQC inspection evaluated the centre’s key services: outpatient…
13 November, 2019
Latest innovations in prostate cancer treatments in the UK
GenesisCare has recently worked with The Jewish Chronicle to raise awareness of our innovations in prostate cancer treatments in the UK. Read our article that appeared in their November Health Supplement on Thursday 14th November 2019, where we take about the MRIdian Linac, spacing gels and 177Lutetium PSMA therapy. Prostate cancer is the most common…
23 October, 2019
Patients to receive innovative treatments in new state-of-the-art cancer centre
Cancer patients will benefit from a £20 million investment that will see a new state-of-the-art diagnostic and treatment centre built in Surrey. Royal Surrey NHS Foundation Trust is working with specialist oncology group GenesisCare to provide the new facility, which is expected to open in late 2021. Eligible NHS patients and staff will have access…
23 September, 2019
‘New hope for advanced prostate cancer patients’
GenesisCare has recently worked with Health Awareness UK and the Guardian on their Urology Health campaign. Read our article that appeared in the Guardian on Monday 23rd September 2019 where Yong Du, Clinical Director, Nuclear Medicine and Theranostics talks about how 177Lutetium PSMA therapy works and it’s benefits to men with late stage prostate cancer…
